Diet drug Qnexa awaits FDA approval amid safety questions
| Qnexa (phentermine and topiramate) Extended-release Capsules is an investigational, once-per-day, weight–loss therapy that combines low doses of two agents approved by the Food and Drug Administration (FDA), phentermine and topiramate, … See all stories on this topic » |
 USA TODAY |
